NuseReal

Special sections: Science, Impact, Response, Good sources

COVID-19 scoreboard: Reported cases and deaths by country, ordered by totals

Another New COVID Variant: BQ.1 and BQ.1.1 Have Arrived — cnet — 7 December 2022 (LINK)

—More than half — about 63% — COVID-19 cases in the US are now caused by variants BQ.1 or BQ.1.1, according to the latest estimate by the US Centers for Disease Control and Prevention. Both are subvariants of omicron. BA.5, the highly contagious omicron subvariant that caused a lot of reinfections or first infections in people who hadn't had COVID-19 this summer and fall, is fading and now only responsible for about 14% of cases.

COVID can live on certain ready-to-eat groceries 'for several days' — ground.news: 10 sources — 2 December 2022 (LINK)

Some goods, including bell peppers, bread, ham and cheese, had infectious virus detected on them several days after they were contaminated. On some surfaces, like croissants, the virus remained present and transmissible for hours.

Study reveals high level of hybrid COVID immunity in general Swiss population — news-medical.net — 18 October 2022 (LINK)

New omicron subvariant BA.2.75.2 largely evades neutralizing antibodies — eurasiareview — 16 October 2022 (LINK)

Omicron BA.5 is declining in the U.S. as other 6 emerging variants gain ground, CDC data shows — cnbc — 14 October 2022 (LINK)

— Three appear to have a growth advantage over BA.5, the most contagious version to date.

Nearly half of COVID survivors haven't fully recovered 6 months later: Study — abcnews — 13 October 2022 (LINK)

Catchup: New Covid variant alert: Meet omicron's newest cousin, BF.7: it can escape the antibodies from earlier illnesses or vaccinations better than the many other omicron sub-variants — livemint — 12 October 2022 (LINK)

BA.2.75.2 COVID variant is worrying experts. Here's why — deseret — 28 September 2022 (LINK)

CDC no longer recommends universal masking in health facilities — thehill — 22 September 2022 (LINK)

WHO 'strongly advises against' use of two COVID treatments: sotrovimab and casirivimab-imdevimab, developed early in pandemic — yahoo — 15 September 2022 (LINK)